Forskning ved Københavns Universitet - Københavns Universitet

Forside

Behandling af gastrointestinal blodning fra angiodysplasier med somatostatinanalogen octreotid

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  • L. Boesby
  • L.O. Kristensen
  • Niels Juel Christensen
Angiodysplasias account for 2-8% of GI-bleeding episodes. We describe a 75-year-old patient with a history of anaemia for 1 year before being diagnosed with multiple angiodysplasias in the GI-tract. The patient needed weekly blood transfusions until he started treatment with octreotide. After 4 months of treatment the need for transfusions had decreased dramatically and faeces was negative for blood. Treatment was switched to long-acting octreotide (Sandostatin Lar). The case illustrates the usefulness of somatostatin analogues in the treatment of bleeding GI-angiodysplasias
Udgivelsesdato: 2008/3/10
OriginalsprogDansk
TidsskriftUgeskrift for læger
Vol/bind170
Udgave nummer11
Sider (fra-til)958-
ISSN0041-5782
StatusUdgivet - 2008

ID: 13834810